Cagrilintide and Amylin Research: Why GLP-1 Is Not the Whole Metabolic Story
GLP-1 gets most of the attention, but amylin research adds a second metabolic signal with its own receptors, brain circuitry, and study questions.
Research Insights
Cagrilintide and Amylin Research: Why GLP-1 Is Not the Whole Metabolic Story
GLP-1 gets most of the attention, but amylin research adds a second metabolic signal with its own receptors, brain circuitry, and study questions.
The metabolic peptide conversation has been dominated by GLP-1 for years. That makes sense: GLP-1 receptor biology is deeply studied, clinically visible, and central to how researchers think about incretin signaling. But GLP-1 is not the only peptide system involved in metabolic regulation.
Amylin is one of the pathways now getting serious attention.
Amylin, also known as islet amyloid polypeptide, is released from pancreatic beta cells alongside insulin. In normal physiology, it helps coordinate nutrient handling after food intake. It is connected to satiety signaling, gastric emptying, glucagon regulation, and brainstem pathways that help the body interpret meal-related signals.